Milestone Pharmaceuticals Inc Sustainability Reports
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its lead commercial-stage product is an innovative nasal spray treatment for transient cardiac conditions like paroxysmal supraventricular tachycardia.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
FIGI: BBG009DR4MP6
1 reports from 2024 to 2024
Company Profile
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its lead commercial-stage product is an innovative nasal spray treatment for transient cardiac conditions like paroxysmal supraventricular tachycardia.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
